Henry Schein Inc (HSIC) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 26 2026 to Sep 27 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Henry Schein Inc   (NASDAQ: HSIC)


Henry Schein Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Henry Schein Inc's ROI in the third quarter of 2026?
Henry Schein Inc achieved a return on average invested assets (ROI) of 5.46 % in its third quarter of 2026, which is below Henry Schein Inc's average return on investment, which stands at 10.32%.

ROI has improved compared to 5.31% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 73 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 26 2026 quarter, so far to 1464, from total ROI ranking in the second quarter of 2026 at 1664.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 26 2026)
III. Quarter		 (Jun 27 2026)
II. Quarter		 (Mar 28 2026)
I. Quarter		 (Dec 27 2025)
IV. Quarter		 (Sep 27 2025)
III. Quarter
Y / Y Investment Change TTM 4.08 % 7.03 % 9.72 % 8.84 % 3.69 %
Y / Y Net Income Change TTM 5.83 % 5.97 % 35.71 % 114.87 % 316.16 %
Investment (TTM) in Millions 7,912 7,893 8,085 8,065 8,029
Return On Investment (TTM) 5.46 % 5.31 % 5.2 % 5.28 % 5.37 %
HSIC's Overall Ranking # 1464 # 1664 # 1309 # 1289 # 1253
Seq. Investment Change TTM -0.36 % -0.27 % 1.4 % 3.29 % 2.46 %
Seq. Net Income Change TTM 2.35 % 1.91 % -0.24 % 1.7 % 2.49 %
Net Income (TTM) in Millions 436 426 418 419 412

HSIC Company Profile >> Back to HSIC Roi Comparisons >> See Annual HSIC Return On Investment



Return On Investment HSIC's Ranking
Within: No.
Industry # 20
Sector # 74
Overall # 1464

Return On Investment Statistics
High Average Low
14.83 %
10.32 %
4.11 %
(Jul 01 2017)   (Sep 28 2024)







Financial Statements
Henry Schein Inc's III. Quarter Investments $ 7,912 Millions HSIC's Balance sheet
Henry Schein Inc's III. Quarter Income $ 119 Millions Quarterly HSIC's Income Statement
HSIC's Income by Division See HSIC's Income by Division


HSIC Annual Return On Investment (Dec 27 2025)
2025		 (Dec 28 2024)
2024		 (Dec 30 2023)
2023		 (Dec 31 2022)
2022		 (Dec 25 2021)
2021
Total Investments in Millions 7,590 7,054 7,526 6,072 5,865
Y / Y Investment Growth 7.6 % -6.27 % 23.95 % 3.54 % 12.33 %
Net Income in Millions 419 398 436 566 661
Y / Y Net Income Growth 5.28 % -8.72 % -22.97 % -14.31 % 57.48 %
Annual Return On Investment 5.52 % 5.64 % 5.79 % 9.32 % 11.26 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 5.52 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HSIC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HSIC's Competitors
Subscribers only: Roi for Henry Schein Inc's Suppliers
Subscribers only: Return On Investment for HSIC's Customers

Other Ratios
HSIC's Roa HSIC's Inventory Turnover Ratio HSIC's Growth Rates HSIC's Dividend Statistics
HSIC's Profitability Ratios HSIC's Asset Turnover Ratio HSIC's Dividend Growth
HSIC's Roe HSIC's Valuation Ratios HSIC's Financial Strength Ratios HSIC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 26 2026, within Healthcare Sector ROI
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %
Medinotec Inc   8.12 %
Pacific Health Care Organization Inc  8.09 %
Quest Diagnostics Inc  8.01 %
Ge Healthcare Technologies Inc   7.60 %
Incyte Corporation  6.81 %
Merit Medical Systems Inc  6.21 %

Date modified: 2026-11-05T14:32:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.